Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The basis for treatment in multiple sclerosis.

A Compston1

  • 1Department of Clinical Neurosciences, University of Cambridge Clinical School, Cambridge, UK. alastair.compston@medschl.cam.ac.uk

Acta Neurologica Scandinavica. Supplementum
|April 28, 2006
PubMed
Summary

Current multiple sclerosis treatments offer limited benefits, failing to halt disease progression or reduce disability. New strategies must address inflammation and promote axonal and myelin repair for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acting on incidental findings in research imaging.

BMJ (Clinical research ed.)·2015
Same author

Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

Genetic burden in multiple sclerosis families.

Genes and immunity·2013
Same author

Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen.

Nature protocols·2011
Same author

Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation.

Cell death and differentiation·2011
Same author

Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.

Genes and immunity·2010

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Current multiple sclerosis (MS) treatments primarily reduce new inflammatory episodes but do not impact disease progression or disability.
  • The complex pathology of MS involves inflammation, axonal injury, compensatory mechanisms, and remyelination, necessitating a multifaceted therapeutic approach.

Purpose of the Study:

  • To analyze the distinct contributions of inflammation, axonal injury, compensatory mechanisms, and remyelination to the clinical features and progression of multiple sclerosis.
  • To identify the need for novel therapeutic strategies that either effectively suppress inflammation early or promote axonal and myelin repair.

Main Methods:

  • This study is a conceptual analysis and review of existing knowledge on multiple sclerosis pathophysiology and treatment limitations.

Related Experiment Videos

  • It synthesizes information on the roles of inflammation, axonal damage, and repair processes in MS.

    • Main Results:

    • Existing MS treatments offer only modest symptomatic relief and do not alter the disease's progressive course.
    • Effective management requires a deeper understanding of the interplay between inflammatory and degenerative processes in MS.

    Conclusions:

    • Future therapeutic strategies for multiple sclerosis must focus on either early, potent suppression of inflammation to prevent axonal damage or the development of regenerative approaches for axonal and myelin repair.
    • Addressing both inflammatory and reparative aspects is crucial for halting MS progression and reducing disability.